Cart
sales@molnova.com
Opaviraline
CAS No. 178040-94-3
Opaviraline( —— )
Catalog No. M34360 CAS No. 178040-94-3
Opaviraline (GW-420867X) is a potent reverse transcriptase inhibitor that inhibits Human immunodeficiency virus 1 and has the potential to treat HIV infection.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 824 | In Stock |
|
| 5MG | 922 | In Stock |
|
| 10MG | 1226 | In Stock |
|
| 25MG | 1853 | In Stock |
|
| 50MG | 2437 | In Stock |
|
| 100MG | 3283 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOpaviraline
-
NoteResearch use only, not for human use.
-
Brief DescriptionOpaviraline (GW-420867X) is a potent reverse transcriptase inhibitor that inhibits Human immunodeficiency virus 1 and has the potential to treat HIV infection.
-
DescriptionOpaviraline (GW-420867X) is a potent reverse transcriptase inhibitor that inhibits Human immunodeficiency virus 1 and has the potential to treat HIV infection.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV Protease
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number178040-94-3
-
Formula Weight280.29
-
Molecular FormulaC14H17FN2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(OC(C)C)(=O)N1C=2C(NC(=O)[C@@H]1CC)=CC=C(F)C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
NBD-557
A potent HIV-1 entry inhibitor that blocks the gp120-CD4 interaction; inhibits the fusion between HIV-1NL4-3-luc pseudotyped virus expressing HIV-1HXB2 (X4-tropic) envelope and U87-T4-CXCR4 cells with IC50 of 9.7 uM.
-
BMS-707035
BMS-707035 is a potent, specific, and reversible HIV-I integrase (IN) inhibitor that blocks HIV IN strand transfer activity with IC50 of 15 nM.
-
HIV-1 inhibitor 18A
HIV-1 inhibitor 18A is a novel broad HIV-1 inhibitor that blocks envelope glycoprotein transitions critical for entry.
